Company Spotlight

Almac Group

Almac House, 20 Seagoe Industrial Estate
Armagh, BT63 5QD
United Kingdom
View Profile

Biosynth Carbosynth

4 Rietlistrasse,
Staad, SG 9422
Switzerland
View Profile

Quotient Sciences

3080 McCann Farm Drive
Garnet Valley, PA 19060
United States
View Profile


Contract Service Directory


MilliporeSigma





Company Headquarters

250 Frankfurter Straße,
Darmstadt, HE 64293
Germany

Contract Service Directory

    Content From MilliporeSigma

    Related Content

    • Biologics, Proteins, Vaccines | Breaking News | Industry News
      MilliporeSigma Accelerates Scale Up of Lipids to Meet Covid Demand

      MilliporeSigma Accelerates Scale Up of Lipids to Meet Covid Demand

      One of a few companies that produces lipids in quantities needed to meet demand for mRNA therapeutics, including Pfizer-BioNTech Covid-19 vaccine.
      Kristin Brooks 05.26.21

    • Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Industry News
      Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center

      Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center

      FUJIFILM Diosynth Biotechnologies will provide GMP contract process development and manufacturing services as part of its role in the new center.
      Contract Pharma Staff 01.14.21

    • Bio News | Biologics, Proteins, Vaccines | Breaking News | Industry News
      MilliporeSigma Acquires AmpTec

      MilliporeSigma Acquires AmpTec

      Expands mRNA capabilities for vaccines, treatments and diagnostics.
      Contract Pharma Staff 01.07.21


    • Breaking News | Industry News
      MilliporeSigma Awards Grant to Combined Therapeutics

      MilliporeSigma Awards Grant to Combined Therapeutics

      Supports its nucleic acid platform that targets liver cancer with virotherapy.
      Contract Pharma Staff 10.28.20

    • Biologics, Proteins, Vaccines | Breaking News | Industry News
      MilliporeSigma Launches VirusExpress Platform

      MilliporeSigma Launches VirusExpress Platform

      Scalable platform increases dose yields and reduces process development time for cell and gene therapies.
      10.13.20

    • Breaking News | Promotions & Moves
      Northwest Biotherapeutics Expands Management Team

      Northwest Biotherapeutics Expands Management Team

      Executive with decades of public and private company experience joins NW Bio as CFO.
      Northwest Biotherapeutics 12.12.19


    • Drug Development | Drug Discovery

    • Drug Development

    • Solid Dosage/Semi-solids
      Pharma Packaging Solutions

      Pharma Packaging Solutions' Scott Garverick

      Pharma Packaging Solutions' vice president of business development discussed company capabilities at Contract Pharma 2019.
      Contract Pharma Staff


    • CPL

      CPL's David Tyler

      CPL's director of business development was on hand at Contract Pharma 2019.
      Contract Pharma




    • Breaking News | Industry News
      VIDEO: Pharma Packaging Solutions

      VIDEO: Pharma Packaging Solutions' Scott Garverick

      Pharma Packaging Solutions' vice president of business development discussed company capabilities at Contract Pharma 2019.
      10.04.19

    • Breaking News | Industry News
      VIDEO: Alcami

      VIDEO: Alcami's Brittany Jackway

      Alcami's senior manager for sales and business development talks with Contract Pharma.
      10.02.19

    • Ophthalmic Drug Delivery for Retinal Disorders

      Ophthalmic Drug Delivery for Retinal Disorders

      This whitepaper explores the development and manufacturing considerations associated with ophthalmic drug delivery, with a focus on retinal disorders.

    • Analytical Services | cGMP Manufacture | Clinical Trial Materials | Drug Development | Industry News
      Permira Funds to Acquire Cambrex in $2.4B Transaction

      Permira Funds to Acquire Cambrex in $2.4B Transaction

      To back Cambrex in its next phase of growth
      08.07.19

    • cGMP Manufacture | Formulation Development | Industry News
      Permira Funds to Acquire Majority Stake in Quotient

      Permira Funds to Acquire Majority Stake in Quotient

      Investment will support Quotient’s growth plans to expand formulation development and manufacturing capabilities
      07.18.19

    • Analytical Services | Chemistry | Drug Development

      The Journey to Redefine the Kilogram

      “Everything Different, Nothing Changes” chronicles the multiyear effort to redefine the kilogram

    • Ampio Appoints Chief Financial Officer

      Ampio Appoints Chief Financial Officer

      Dan Stokely brings more than 30 years of experience in finance and accounting
      07.10.19